Hawaii 2023 Regular Session

Hawaii Senate Bill SR139 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	THE SENATE S.R. NO. 139 THIRTY-SECOND LEGISLATURE, 2023 STATE OF HAWAII SENATE RESOLUTION REQUESTING insurance COVERAGE For KETAMINE THERAPY FOR QUALIFYING PATIENTS.
2	2
3	3	THE SENATE S.R. NO. 139
4	4	THIRTY-SECOND LEGISLATURE, 2023
5	5	STATE OF HAWAII
6	6
7	7	THE SENATE
8	8
9	9	S.R. NO.
10	10
11	11	139
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2023
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29	SENATE RESOLUTION
30	30
31	31
32	32
33	33
34	34
35	35	REQUESTING insurance COVERAGE For KETAMINE THERAPY FOR QUALIFYING PATIENTS.
36	36
37	37
38	38
39	39
40	40
41	41	WHEREAS, the State has a duty to protect and improve the health and environment of the people; and WHEREAS, a number of state residents suffer from depression; and WHEREAS, according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression, and has rapid antidepressant effects; and WHEREAS, ketamine therapy would bring relief to many state residents who suffer from depression; now, therefore, BE IT RESOLVED by the Senate of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2023, that beginning on January 1, 2024, the State's Medicaid programs are requested to provide coverage for percent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals; and BE IT FURTHER RESOLVED that each individual or group accident and health or sickness insurance policy issued or renewed in this State on or after January 1, 2024, is requested to provide to the policyholder and individuals covered under the policy coverage for percent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals; and BE IT FURTHER RESOLVED that each hospital or medical service plan contract issued or renewed in this State on or after January 1, 2024, is requested to provide to the member and individuals covered under the plan contract coverage for percent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Director of Human Services and the Insurance Commissioner, the latter of whom is requested to distribute copies of this measure to the entities administering the insurance policies and service plan contracts addressed in this measure. OFFERED BY: _____________________________ Report Title: Ketamine; Therapy; Treatment; Medicaid; Insurance; Coverage
42	42
43	43	WHEREAS, the State has a duty to protect and improve the health and environment of the people; and
44	44
45	45
46	46
47	47	WHEREAS, a number of state residents suffer from depression; and
48	48
49	49
50	50
51	51	WHEREAS, according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression, and has rapid antidepressant effects; and
52	52
53	53
54	54
55	55	WHEREAS, ketamine therapy would bring relief to many state residents who suffer from depression; now, therefore,
56	56
57	57
58	58
59	59	BE IT RESOLVED by the Senate of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2023, that beginning on January 1, 2024, the State's Medicaid programs are requested to provide coverage for percent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals; and
60	60
61	61
62	62
63	63	BE IT FURTHER RESOLVED that each individual or group accident and health or sickness insurance policy issued or renewed in this State on or after January 1, 2024, is requested to provide to the policyholder and individuals covered under the policy coverage for percent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals; and
64	64
65	65
66	66
67	67	BE IT FURTHER RESOLVED that each hospital or medical service plan contract issued or renewed in this State on or after January 1, 2024, is requested to provide to the member and individuals covered under the plan contract coverage for percent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals; and
68	68
69	69
70	70
71	71	BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Director of Human Services and the Insurance Commissioner, the latter of whom is requested to distribute copies of this measure to the entities administering the insurance policies and service plan contracts addressed in this measure.
72	72
73	73
74	74
75	75
76	76
77	77
78	78
79	79	OFFERED BY: _____________________________
80	80
81	81
82	82
83	83	OFFERED BY:
84	84
85	85	_____________________________
86	86
87	87
88	88
89	89
90	90
91	91	Report Title:
92	92
93	93	Ketamine; Therapy; Treatment; Medicaid; Insurance; Coverage